What is Hims & Hers Health Inc's earnings per share (EPS)?

Hims & Hers Health Inc (HIMS) reported diluted earnings per share of $0.51 for fiscal year 2025. This represents a -3.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Hims & Hers Health Inc Financials

HIMS

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Hims & Hers Health Inc (HIMS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 50/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Hims & Hers Health Inc has an operating margin of 4.5%, meaning the company retains $5 of operating profit per $100 of revenue. This results in a moderate score of 32/100, indicating healthy but not exceptional operating efficiency. This is up from 4.2% the prior year.

Growth

100

Hims & Hers Health Inc's revenue surged 59.0% year-over-year to $2.3B, reflecting rapid business expansion. This strong growth earns a score of 100/100.

Leverage

Hims & Hers Health Inc has a moderate D/E ratio of 2.98. This balance of debt and equity financing earns a leverage score of 41/100.

Liquidity

Hims & Hers Health Inc's current ratio of 1.90 indicates adequate short-term liquidity, earning a score of 34/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

While Hims & Hers Health Inc generated $300.0M in operating cash flow, capex of $242.6M consumed most of it, leaving $57.4M in free cash flow. This results in a low score of 31/100, reflecting heavy capital investment rather than weak cash generation.

Returns

Hims & Hers Health Inc's ROE of 23.7% shows moderate profitability relative to equity, earning a score of 64/100. This is down from 26.4% the prior year.

Altman Z-Score Safe

3.14

Hims & Hers Health Inc scores 3.14, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($4.7B) relative to total liabilities ($1.6B). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Piotroski F-Score Neutral

4/9

Hims & Hers Health Inc passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

2.34x

For every $1 of reported earnings, Hims & Hers Health Inc generates $2.34 in operating cash flow ($300.0M OCF vs $128.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.3B

YoY+59.0%

5Y CAGR+73.6%

Hims & Hers Health Inc generated $2.3B in revenue in fiscal year 2025. This represents an increase of 59.0% from the prior year.

EBITDA

$160.1M

YoY+102.7%

Hims & Hers Health Inc's EBITDA was $160.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 102.7% from the prior year.

Net Income

$128.4M

YoY+1.8%

Hims & Hers Health Inc reported $128.4M in net income in fiscal year 2025. This represents an increase of 1.8% from the prior year.

EPS (Diluted)

$0.51

YoY-3.8%

Hims & Hers Health Inc earned $0.51 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 3.8% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$57.4M

YoY-71.0%

Hims & Hers Health Inc generated $57.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 71.0% from the prior year.

Cash & Debt

$228.6M

YoY+3.6%

5Y CAGR+52.9%

Hims & Hers Health Inc held $228.6M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

N/A

Margins & Returns

Gross Margin

73.8%

YoY-5.6pp

5Y CAGR+0.3pp

Hims & Hers Health Inc's gross margin was 73.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 5.6 percentage points from the prior year.

Operating Margin

4.5%

YoY+0.3pp

5Y CAGR+14.7pp

Hims & Hers Health Inc's operating margin was 4.5% in fiscal year 2025, reflecting core business profitability. This is up 0.3 percentage points from the prior year.

Net Margin

5.5%

YoY-3.1pp

5Y CAGR+17.6pp

Hims & Hers Health Inc's net profit margin was 5.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 3.1 percentage points from the prior year.

Return on Equity

23.7%

YoY-2.7pp

Hims & Hers Health Inc's ROE was 23.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 2.7 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

$90.0M

YoY+8.3%

Hims & Hers Health Inc spent $90.0M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 8.3% from the prior year.

Capital Expenditures

$242.6M

YoY+359.5%

Hims & Hers Health Inc invested $242.6M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 359.5% from the prior year.

HIMS Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$2.3B+59.0%	$1.5B+69.3%	$872.0M+65.5%	$526.9M+93.8%	$271.9M+82.8%	$148.8M
Cost of Revenue	$614.3M+102.5%	$303.4M+93.2%	$157.1M+32.9%	$118.2M+75.4%	$67.4M+71.4%	$39.3M
Gross Profit	$1.7B+47.8%	$1.2B+64.1%	$714.9M+74.9%	$408.7M+99.9%	$204.5M+86.8%	$109.5M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$272.7M+62.6%	$167.8M+29.2%	$129.9M+32.3%	$98.2M-46.5%	$183.6M+179.9%	$65.6M
Operating Income	$105.6M+70.6%	$61.9M+310.2%	-$29.5M+57.1%	-$68.7M+40.3%	-$115.0M-659.7%	-$15.1M
Interest Expense	N/A	N/A	N/A	N/A	$0-100.0%	$10K
Income Tax	-$4.4M+91.8%	-$54.3M-2850.7%	$2.0M+6471.0%	-$31K+99.0%	-$3.1M-2569.3%	$127K
Net Income	$128.4M+1.8%	$126.0M+635.3%	-$23.5M+64.1%	-$65.7M+39.0%	-$107.7M-494.3%	-$18.1M
EPS (Diluted)	$0.51-3.8%	$0.53+581.8%	$-0.11+65.6%	$-0.32+44.8%	$-0.58-13.7%	$-0.51

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$617.8M+3.1%	$599.0M+9.9%	$544.8M-7.0%	$586.0M+21.8%	$481.1M+19.8%	$401.6M+27.2%	$315.6M+13.5%	$278.2M
Cost of Revenue	$173.4M+10.5%	$156.9M+22.0%	$128.6M-17.2%	$155.3M+39.2%	$111.6M+33.4%	$83.7M+41.7%	$59.0M+20.3%	$49.1M
Gross Profit	$444.4M+0.5%	$442.1M+6.2%	$416.2M-3.4%	$430.7M+16.5%	$369.5M+16.2%	$317.9M+23.9%	$256.6M+12.0%	$229.1M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$76.2M-5.6%	$80.7M+19.9%	$67.3M+38.4%	$48.6M+1.2%	$48.0M+7.6%	$44.6M+10.0%	$40.6M+17.3%	$34.6M
Operating Income	$9.2M-22.2%	$11.8M-55.8%	$26.7M-53.8%	$57.9M+211.3%	$18.6M-16.9%	$22.4M+102.8%	$11.0M+11.4%	$9.9M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	-$2.2M+36.7%	-$3.6M+63.2%	-$9.7M-187.7%	$11.0M+394.9%	-$3.7M+92.8%	-$52.0M-41040.9%	$127K-90.0%	$1.3M
Net Income	$20.6M+30.6%	$15.8M-62.9%	$42.5M-14.1%	$49.5M+90.1%	$26.0M-65.6%	$75.6M+468.5%	$13.3M+19.5%	$11.1M
EPS (Diluted)	N/A	$0.06-64.7%	$0.17-15.0%	$0.20	N/A	$0.32+433.3%	$0.06+20.0%	$0.05

HIMS Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$2.2B+204.5%	$707.5M+60.4%	$441.2M+20.4%	$366.3M-12.9%	$420.6M+254.3%	$118.7M
Current Assets	$767.6M+93.9%	$395.8M+49.3%	$265.1M+22.4%	$216.6M-19.8%	$269.9M+138.7%	$113.1M
Cash & Equivalents	$228.6M+3.6%	$220.6M+128.2%	$96.7M+106.7%	$46.8M-34.8%	$71.8M+162.5%	$27.3M
Inventory	$80.1M+24.4%	$64.4M+186.8%	$22.5M+4.2%	$21.6M+59.0%	$13.6M+282.7%	$3.5M
Accounts Receivable	$32.1M+426.2%	$6.1M-9.0%	$6.7M+71.8%	$3.9M-4.9%	$4.1M+272.7%	$1.1M
Goodwill	$278.3M+146.9%	$112.7M+1.7%	$110.9M0.0%	$110.9M0.0%	$110.9M	$0
Total Liabilities	$1.6B+599.1%	$230.8M+137.6%	$97.2M+77.9%	$54.6M-36.5%	$86.0M-67.6%	$265.6M
Current Liabilities	$404.4M+82.7%	$221.4M+150.2%	$88.5M+84.5%	$47.9M-39.5%	$79.2M+420.2%	$15.2M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$540.9M+13.5%	$476.7M+38.6%	$344.0M+10.4%	$311.7M-6.8%	$334.6M+327.8%	-$146.9M
Retained Earnings	-$113.8M+53.0%	-$242.1M+34.2%	-$368.2M-6.8%	-$344.6M-23.5%	-$279.0M-62.9%	-$171.3M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$2.2B-3.5%	$2.2B+18.9%	$1.9B+110.6%	$891.7M+26.0%	$707.5M+17.5%	$602.3M+25.3%	$480.5M+7.2%	$448.1M
Current Assets	$767.6M-9.2%	$845.3M-37.6%	$1.4B+203.3%	$447.0M+12.9%	$395.8M+21.3%	$326.4M+12.2%	$290.9M+11.2%	$261.7M
Cash & Equivalents	$228.6M-33.9%	$345.8M-69.3%	$1.1B+310.8%	$273.7M+24.1%	$220.6M+33.3%	$165.5M+28.0%	$129.3M+22.9%	$105.2M
Inventory	$80.1M-24.4%	$106.0M-25.3%	$141.8M+86.3%	$76.1M+18.1%	$64.4M+31.2%	$49.1M+21.0%	$40.6M+36.1%	$29.8M
Accounts Receivable	$32.1M	N/A	N/A	N/A	$6.1M	N/A	N/A	N/A
Goodwill	$278.3M+7.4%	$259.2M+120.2%	$117.8M0.0%	$117.8M+4.5%	$112.7M0.0%	$112.7M+1.7%	$110.9M0.0%	$110.9M
Total Liabilities	$1.6B-2.3%	$1.7B+25.7%	$1.3B+284.0%	$342.4M+48.4%	$230.8M+42.3%	$162.2M+36.8%	$118.5M+14.4%	$103.6M
Current Liabilities	$404.4M-10.3%	$450.8M+65.6%	$272.2M-2.9%	$280.4M+26.7%	$221.4M+45.0%	$152.6M+40.5%	$108.7M+16.4%	$93.3M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$540.9M-6.9%	$581.0M+3.2%	$562.7M+2.4%	$549.3M+15.2%	$476.7M+8.3%	$440.1M+21.6%	$362.0M+5.1%	$344.5M
Retained Earnings	-$113.8M+15.3%	-$134.4M+10.5%	-$150.1M+22.1%	-$192.7M+20.4%	-$242.1M+9.7%	-$268.2M+22.0%	-$343.8M+3.7%	-$357.0M

HIMS Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$300.0M+19.5%	$251.1M+241.7%	$73.5M+377.0%	-$26.5M+22.9%	-$34.4M-1288.1%	-$2.5M
Capital Expenditures	$242.6M+359.5%	$52.8M+99.2%	$26.5M+268.1%	$7.2M	N/A	N/A
Free Cash Flow	$57.4M-71.0%	$198.3M+322.0%	$47.0M+239.3%	-$33.7M	N/A	N/A
Investing Cash Flow	-$1.0B-5280.9%	-$19.0M-57.3%	-$12.1M-134.9%	$34.7M+122.2%	-$156.3M-293.6%	-$39.7M
Financing Cash Flow	$729.6M+776.5%	-$107.8M-839.8%	-$11.5M+65.4%	-$33.1M-114.1%	$235.0M+392.3%	$47.7M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$90.0M+8.3%	$83.0M+4054.0%	$2.0M	$0	$0	$0

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$61.3M-58.8%	$148.7M+878.0%	-$19.1M-117.5%	$109.1M+26.3%	$86.4M+1.3%	$85.3M+59.1%	$53.6M+107.4%	$25.8M
Capital Expenditures	$63.9M-7.9%	$69.4M+37.7%	$50.4M-14.6%	$59.0M+119.3%	$26.9M+355.9%	$5.9M-1.7%	$6.0M-57.1%	$14.0M
Free Cash Flow	-$2.6M-103.3%	$79.3M+214.1%	-$69.5M-238.8%	$50.1M-15.8%	$59.5M-25.1%	$79.4M+66.8%	$47.6M+302.0%	$11.8M
Investing Cash Flow	-$83.7M+90.6%	-$887.4M-4108.1%	-$21.1M+35.7%	-$32.8M-90.6%	-$17.2M-65.2%	-$10.4M-133.0%	-$4.5M-134.3%	$13.0M
Financing Cash Flow	-$97.5M-150.0%	-$39.0M-104.4%	$889.2M+3962.9%	-$23.0M-68.6%	-$13.7M+64.8%	-$38.8M-54.9%	-$25.1M+17.3%	-$30.3M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$80.5M+749.0%	$9.5M	$0	$0-100.0%	$5.0M-83.3%	$30.0M+50.7%	$19.9M-29.0%	$28.1M

HIMS Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	73.8%-5.6pp	79.5%-2.5pp	82.0%+4.4pp	77.6%+2.3pp	75.2%+1.6pp	73.6%
Operating Margin	4.5%+0.3pp	4.2%+7.6pp	-3.4%+9.7pp	-13.0%+29.3pp	-42.3%-32.1pp	-10.2%
Net Margin	5.5%-3.1pp	8.5%+11.2pp	-2.7%+9.8pp	-12.5%+27.1pp	-39.6%-27.4pp	-12.2%
Return on Equity	23.7%-2.7pp	26.4%+33.3pp	-6.8%+14.2pp	-21.1%+11.1pp	-32.2%	N/A
Return on Assets	6.0%-11.9pp	17.8%+23.2pp	-5.3%+12.6pp	-17.9%+7.7pp	-25.6%-10.3pp	-15.3%
Current Ratio	1.90+0.1	1.79-1.2	3.00-1.5	4.52+1.1	3.41-4.0	7.43
Debt-to-Equity	2.98+2.5	0.48+0.2	0.28+0.1	0.18-0.1	0.26+2.1	-1.81
FCF Margin	2.5%-11.0pp	13.4%+8.0pp	5.4%+11.8pp	-6.4%	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	71.9%-1.9pp	73.8%-2.6pp	76.4%+2.9pp	73.5%-3.3pp	76.8%-2.3pp	79.2%-2.1pp	81.3%-1.1pp	82.4%
Operating Margin	1.5%-0.5pp	2.0%-2.9pp	4.9%-5.0pp	9.9%+6.0pp	3.9%-1.7pp	5.6%+2.1pp	3.5%-0.1pp	3.6%
Net Margin	3.3%+0.7pp	2.6%-5.2pp	7.8%-0.6pp	8.4%+3.0pp	5.4%-13.4pp	18.8%+14.6pp	4.2%+0.2pp	4.0%
Return on Equity	3.8%+1.1pp	2.7%-4.8pp	7.5%-1.5pp	9.0%+3.5pp	5.5%-11.7pp	17.2%+13.5pp	3.7%+0.4pp	3.2%
Return on Assets	1.0%+0.2pp	0.7%-1.5pp	2.3%-3.3pp	5.5%+1.9pp	3.7%-8.9pp	12.6%+9.8pp	2.8%+0.3pp	2.5%
Current Ratio	1.90+0.0	1.88-3.1	4.98+3.4	1.59-0.2	1.79-0.4	2.14-0.5	2.68-0.1	2.80
Debt-to-Equity	2.98+0.1	2.84+0.5	2.34+1.7	0.62+0.1	0.48+0.1	0.37+0.0	0.33+0.0	0.30
FCF Margin	-0.4%-13.7pp	13.2%+26.0pp	-12.8%-21.3pp	8.6%-3.8pp	12.4%-7.4pp	19.8%+4.7pp	15.1%+10.8pp	4.3%

Similar Companies

Clorox Co Del CLX

$12.4B

Church & Dwight Co Inc CHD

$22.2B

Kenvue Inc. KVUE

$33.0B

Estee Lauder Companies EL

$24.6B

Kimberly-Clark Corp KMB

$32.0B

Frequently Asked Questions

What is Hims & Hers Health Inc's annual revenue?

Hims & Hers Health Inc (HIMS) reported $2.3B in total revenue for fiscal year 2025. This represents a 59.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Hims & Hers Health Inc's revenue growing?

Hims & Hers Health Inc (HIMS) revenue grew by 59% year-over-year, from $1.5B to $2.3B in fiscal year 2025.

Is Hims & Hers Health Inc profitable?

Yes, Hims & Hers Health Inc (HIMS) reported a net income of $128.4M in fiscal year 2025, with a net profit margin of 5.5%.

What is Hims & Hers Health Inc's EBITDA?

Hims & Hers Health Inc (HIMS) had EBITDA of $160.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Hims & Hers Health Inc's gross margin?

Hims & Hers Health Inc (HIMS) had a gross margin of 73.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Hims & Hers Health Inc's operating margin?

Hims & Hers Health Inc (HIMS) had an operating margin of 4.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Hims & Hers Health Inc's net profit margin?

Hims & Hers Health Inc (HIMS) had a net profit margin of 5.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Hims & Hers Health Inc's return on equity (ROE)?

Hims & Hers Health Inc (HIMS) has a return on equity of 23.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Hims & Hers Health Inc's free cash flow?

Hims & Hers Health Inc (HIMS) generated $57.4M in free cash flow during fiscal year 2025. This represents a -71.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Hims & Hers Health Inc's operating cash flow?

Hims & Hers Health Inc (HIMS) generated $300.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Hims & Hers Health Inc's total assets?

Hims & Hers Health Inc (HIMS) had $2.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Hims & Hers Health Inc's capital expenditures?

Hims & Hers Health Inc (HIMS) invested $242.6M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Hims & Hers Health Inc buy back shares?

Yes, Hims & Hers Health Inc (HIMS) spent $90.0M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

What is Hims & Hers Health Inc's current ratio?

Hims & Hers Health Inc (HIMS) had a current ratio of 1.90 as of fiscal year 2025, which is generally considered healthy.

What is Hims & Hers Health Inc's debt-to-equity ratio?

Hims & Hers Health Inc (HIMS) had a debt-to-equity ratio of 2.98 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Hims & Hers Health Inc's return on assets (ROA)?

Hims & Hers Health Inc (HIMS) had a return on assets of 6.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Hims & Hers Health Inc's Altman Z-Score?

Hims & Hers Health Inc (HIMS) has an Altman Z-Score of 3.14, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Hims & Hers Health Inc's Piotroski F-Score?

Hims & Hers Health Inc (HIMS) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Hims & Hers Health Inc's earnings high quality?

Hims & Hers Health Inc (HIMS) has an earnings quality ratio of 2.34x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Hims & Hers Health Inc?

Hims & Hers Health Inc (HIMS) scores 50 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.